Table 1 Demographic and risk factors of included PAD patients
From: Presentation and outcomes of indigenous Australians with peripheral artery disease
Characteristics | Indigenous (n = 16) | Non-Indigenous (n = 385) | p-value |
|---|---|---|---|
Age (y) | 63.3 (54.7–67.8) | 69.6 (63.3–75.4) | 0.005 |
Sex (% Males) | 10 (62.5%) | 293 (76.1%) | 0.215 |
Diabetes mellitus | 7 (43.8%) | 103 (26.8%) | 0.135 |
Smoker | 0.041 | ||
Never | 0 (0%) | 82 (21.3%) | |
Current | 9 (56.3%) | 121 (31.4%) | |
Previous | 7 (43.8%) | 182 (47.3%) | |
Hypertension | 15 (93.8%) | 290 (75.3%) | 0.091 |
IHD | 10 (62.5%) | 164 (42.6%) | 0.116 |
Stroke | 1 (6.3%) | 38 (9.9%) | 0.632 |
eGFR (mL/min/1.73m2) | 79.0 (46.5–85.8) [2]a | 78 (60.0–91.0) [93]a | 0.416 |
Medications | |||
Aspirin | 11 (68.88%) | 252 (65.5%) | 0.786 |
Other antiplatelet | 3 (18.8%) | 66 (17.1%) | 0.867 |
Frusemide | 4 (25.0%) | 28 (7.3%) | 0.010 |
ACEI | 10 (62.5%) | 152 (39.5%) | 0.066 |
Beta-Blocker | 6 (37.5%) | 115 (29.9%) | 0.515 |
Calcium channel blocker | 3 (18.8%) | 115 (29.9%) | 0.339 |
Metformin | 4 (25.0%) | 69 (17.9%) | 0.472 |
Insulin | 3 (18.8%) | 20 (5.2%) | 0.022 |
Statin | 13 (81.3%) | 273 (70.9%) | 0.370 |